Mechanistically, gain‐ and loss‐of‐function experiments demonstrated that miR‐223‐3p targets NLRP3 in order to suppress inflammasome activation and pyroptosis, highlighting the potential of miR‐223‐3p as a therapeutic target for the clinical treatment of syphilis. Here, NLRP3 is linked to syphilis.